Clarity Pharmaceuticals Limited

Australia


 
Total IP 46
Total IP Rank # 30,461
IP Activity Score 2.6/5.0    49
IP Activity Rank # 15,095
Stock Symbol CU6 (asx)
ISIN AU0000165375
Market Cap. 1.8000001B  (AUD)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

25 6
3 0
12 0
0
 
Last Patent 2025 - Radiopharmaceuticals, radioimagi...
First Patent 2009 - Nitrogen-containing macrocyclic ...
Last Trademark 2024 - CLARITY PHARMACEUTICALS
First Trademark 2024 - CLARITY PHARMACEUTICALS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Radiopharmaceuticals, radioimaging agents, and uses thereof. The present invention relates to co...
G/S Retail store services featuring pharmaceuticals, pharmaceutical preparations and supplements, med...
G/S Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for the treatme...
G/S Pharmaceuticals and other preparations for medical and veterinary purposes, namely, radioactive p...
Invention Methods for the diagnosis and/or treatment of neuroendocrine cancers. The present invention relat...
Invention Methods for the diagnosis and/or treatment of prostate cancer. The present invention relates gene...
Invention Targeting compounds and methods for their production. The present invention is directed to sarco...
Invention Methods for the detection and diagnosis of cancers associated with overexpression of a psma recep...
Invention Formulations for radiotherapy and diagnostic imaging. The present invention relates to formulati...
2023 Invention Compounds for radioimaging and treatment of a cancer. The present invention relates to compounds ...
Invention Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals. The present invention relate...
Invention Identification and/or treatment of cancer. The present invention relates generally to the identif...
Invention Formulations for radiotherapy and diagnostic imaging and use thereof in treatment, diagnosis and ...
Invention Dimeric radiopharmaceuticals, compositions thereof and uses thereof. The present invention relate...
Invention Radiopharmaceuticals, radioimaging agents, and uses thereof. The present invention relates to com...
Invention Formulations and kits for radiotherapy and diagnostic imaging. Aqueous formulations and kits of ...
2022 Invention Compounds and compositions thereof for the treatment of cancer. The present invention relates to...
Invention Compounds and compositions thereof for the treatment of cancer. The present invention relates to ...
Invention Radiopharmaceuticals, methods for the production thereof, and uses in treatment, diagnosis and im...
2021 Invention Radiopharmaceuticals, uses thereof, and methods for the production thereof. Radiopharmaceutical ...
Invention Radiopharmaceuticals, uses thereof, and methods for the production thereof. Radiopharmaceutical c...
Invention Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals. The present invention relates...
2020 Invention Radiolabelled targeting ligands. The present invention relates to compounds that are useful as r...
Invention Radiolabelled targeting ligands. The present invention relates to compounds that are useful as ra...
Invention Formulations of psma imaging agents. The present invention relates to formulations of radiolabel...
Invention Formulations of psma imaging agents. The present invention relates to formulations of radiolabele...
2019 Invention Targeting compounds and methods for their production. The present invention is directed to sarcop...
Invention Formulations and kits for radiotherapy and diagnostic imaging. Aqueous formulations and kits of r...
2017 Invention Formulations for radiotherapy and diagnostic imaging. The present invention relates to stable for...
2016 Invention Cage amine ligands for metallo-radiopharmaceuticals. The present invention relates to compounds t...
2012 Invention Functionalisation of cage amine ligands for metallo-radiopharmaceuticals. The present invention r...